Colorectal cancer (CRC) is the second most common cause of cancer-related deaths in
Europe and other Western countries, mainly due to the lack of well-validated clinically useful …

The fact that cancer is a leading cause of death all around the world has naturally sparked
major efforts in the pursuit of novel and more efficient biomarkers that could better serve as …

Background: Pancreatic carcinoma (PC) is an aggressive malignancy that lacks strategies
for early detection. This study aimed to develop a coherent, high-throughput and non …

Prior to the advent of genetic engineering in the mouse, the rat was the model of choice for
investigating the etiology of cancer. Now, recent advances in the manipulation of the rat …

Background A major roadblock to reducing the mortality of colorectal cancer (CRC) is
prompt detection and treatment, and a simple blood test is likely to have higher compliance …

In the oncological area, pancreatic cancer is one of the most lethal diseases, with 5-year
survival rising just 10% in high-development countries. This disease is genetically …

Objective. Inter‐alpha‐trypsin inhibitor heavy chain H3 (ITIH3) and inter‐alpha‐trypsin
inhibitor heavy chain H4 (ITIH4) are heavy chains of protein members belonging to the ITI …

Background: Colorectal cancer (CRC) prognosis is determined by the disease stage with
low survival rates for advanced stages. Current CRC screening programs are mainly using …

Platinum resistance of ovarian cancer is one of the primary factors of poor prognosis and
inter-α-trypsin inhibitor heavy chain 3 (ITIH3) is a potential DDP resistance-associated gene …

Several alkaloids found in the Zanthoxylum genus have demonstrated significant anticancer
activity. However, the antitumor effects of Ethoxychelerythrine (Eth) have not been previously …